What is Plume?
Plume operates at the intersection of digital health and patient-centered care, providing gender-affirming hormone therapy via a specialized telehealth platform. By removing traditional geographic and systemic barriers, the company has established a scalable model that serves the trans-community across the United States. Plume's market position is defined by its commitment to clinical excellence and accessible, inclusive healthcare, positioning it as a critical player in the rapidly evolving virtual care sector. The company's growth trajectory reflects a broader industry shift toward niche, high-impact telehealth solutions that address the specific needs of underserved populations.
How much funding has Plume raised?
Plume has raised a total of $38M across 2 funding rounds:
Series A
$14M
Series B
$24M
Series A (2021): $14M with participation from Slow Ventures, General Catalyst, Town Hall Ventures, and Craft Ventures
Series B (2022): $24M led by Transformation Capital, General Catalyst, and Townhall Ventures
Key Investors in Plume
Transformation Capital
Founded in 2015 and headquartered in Boston, Massachusetts, Transformation Capital is a growth equity fund fully focused on innovative healthcare IT and services companies.
General Catalyst
General Catalyst operates as a venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors and stages, with a strong emphasis on healthcare innovation.
Town Hall Ventures
Town Hall Ventures partners with founders addressing long-standing healthcare challenges for underserved communities, focusing on innovative solutions to improve health outcomes.
What's next for Plume?
With this major enterprise-level funding, Plume is well-positioned to accelerate its operational scaling and enhance its service offerings. The strategic focus will likely center on expanding its provider network, refining its digital patient experience, and deepening its integration within the broader healthcare ecosystem. As the company moves beyond its initial growth phase, the focus will shift toward long-term sustainability and the potential for broader clinical service expansion, ensuring that its telehealth platform remains a cornerstone for accessible, high-quality care in an increasingly digital-first medical environment.
See full Plume company page
